Sglt2 Inhibitors Have Heart Benefits For Type 2 Diabetes Patients | Latest News RSS feed

Sglt2 Inhibitors Have Heart Benefits For Type 2 Diabetes Patients - Latest News


Do type 2 diabetes drugs contribute to cardiovascular diseases?

In the most common variety, type 2 diabetes, insulin levels are decreased or there is an inadequate response to insulin. Gestational diabetes occurs during pregnancy. Patients with diabetes have a hig... read more

New data from landmark CVD-REAL study of patients with type-2 diabetes confirms CV benefits associated with SGLT-2 inhibitors

Real-world evidence study of more than 400,000 patients with type-2 diabetes, 74% of whom did not have a history of established ... Lower risk of heart failure and death in patients initiated on SGLT- ... read more

AstraZeneca announces CVD-REAL study of patients with T2D confirms CV benefits associated with SGLT-2 inhibitors

and stroke in patients with type-2 diabetes (T2D) receiving treatment with SGLT-2 inhibitors (SGLT-2i), including Farxiga (dapagliflozin) versus other glucose-lowering medicines. The results were pres... read more

Looking for another news?


Differences Between Type 1 and Type 2 Diabetes

Many patients with Type 1 diabetes are diagnosed because they have ... SGLT-2 inhibitors and insulin. In addition to medications, your doctor might prescribe low-dose aspirin therapy to prevent ... read more


Type 2 Diabetes Therapies: A STEPS Approach

Now, family physicians have ... in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J. 2004;25(1):10–16. 19. Van de Laar FA, Lucassen PL, Akkermans RP, et al. Alpha-glucos... read more

John Buse Part 3, SGLT2 Inhibitors Effects On Amputations And Cardiovascular Disease

The American Diabetes Association is a great resource, but their website, it’s not like they have a thing, “What would I do for a patient with neuropathy who’s had a prior amputation but has heart fai... read more

Cardiovascular Results for Dapagliflozin Point to SGLT2 Use to Prevent Heart Failure

Results presented at the American Heart Association ... heart failure specialists have discussed for several years now: the possibility that SGLT2 inhibitors might be used to prevent heart failure in ... read more

Diabetes Health Podcast News: Is There a Link Between SGLT2 Inhibitors and Urinary Tract Infections?

If you’ve been prescribed a sodium-glucose cotransporter-2 (SGLT2) inhibitor ... diabetes and experienced the full court of the diabetes spectrum with my type 2 family members and type 1 husband of al... read more

SGLT2 inhibitors morph into HF drugs

The oral sodium-glucose cotransporter-2 (SGLT2) inhibitors are the focus of a slew of ongoing phase 3 clinical trials in patients with ... these trials has diabetes. All have symptomatic heart failure ... read more

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

Adjunct to insulin The results demonstrate that when this drug, a sodium glucose cotransporter-2 inhibitor (SGLT-2 ... for use in Type 1 diabetes," he said. "We have been pioneers in conceptualizing n... read more

Certain Patients with Type 2 Diabetes Less Likely to Suffer Heart Failure While Taking New Class of Antidiabetic Drug

The study is the first to report a direct comparison of SGLT2 and DPP4 inhibitors on the risk of heart failure hospitalization. People with type 2 diabetes ... patients who use other medications. “Thi... read more

Expert Consensus Decision Pathway Addresses Changing Paradigm in Managing T2D Patients With ASCVD

The ACC's 2018 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients ... diabetes medications, the GLP-1 receptor agonists and SGLT-2 inhibitors. Reducing ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us